MoonLake Immunotherapeutics
Stock Chart, Company Information, and Scan Results
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
MoonLake Immunotherapeutics Company Information, Fundamentals, and Technical Indicators
MoonLake Immunotherapeutics, a clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.
MoonLake Immunotherapeutics In Our Stock Scanner
As of Sep 30, 2025Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.